Results
|
26841.
|
|
|
26842.
|
|
|
26843.
|
|
|
26844.
|
|
|
26845.
|
|
|
26846.
|
|
|
26847.
|
|
|
26848.
|
|
|
26849.
|
|
|
26850.
|
|
|
26851.
|
|
|
26852.
|
|
|
26853.
|
|
|
26854.
|
|
|
26855.
|
Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome. [electronic resource] by
- Ozmen, V
- Cabioglu, N
- Dolay, K
- Bilir, A
- Kecer, M
- Aydiner, A
- Muslumanoglu, M
- Igci, A
- Bozfakioglu, Y
- Dagoglu, T
Producer: 20020219
In:
Breast cancer research and treatment vol. 68
Availability: No items available.
|
|
26856.
|
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study. [electronic resource] by
- Conte, P F
- Gennari, A
- Donati, S
- Salvadori, B
- Baldini, E
- Bengala, C
- Pazzagli, I
- Orlandini, C
- Danesi, R
- Fogli, S
- Del Tacca, M
Producer: 20020219
In:
Breast cancer research and treatment vol. 68
Availability: No items available.
|
|
26857.
|
|
|
26858.
|
|
|
26859.
|
|
|
26860.
|
|